Abstract
Skeletal disorders can be grouped by their etiology and pathophysiology into a variety of entities, including metabolic diseases, tumors, matrix disorders, and inflammatory conditions. The pathophysiological spectrum of chronic inflammatory disorders of bone tissue ranges from autoimmune diseases to diseases which present with autoinflammatory characteristics [31]. In general, autoinflammatory diseases are characterized by chronic inflammation without evidence of autoimmunity (e.g., autoantibodies or autoreactive T cells) and may affect various tissues, including the skeletal system [28]. Autoinflammatory bone disorders result from a dysregulation of the innate immune system with subsequent inflammatory cellular infiltration of the bone, increased osteoclast activity, osteolysis, and bone remodeling [9, 15]. Chronic/recurrent noninfectious osteomyelitis is the common denominator of all autoinflammatory bone diseases. The recurrent disease course in the absence of microorganisms at the site of inflammation and the lack of high-titer autoantibodies and/or autoreactive T lymphocytes have led to the inclusion of this disease in the group of autoinflammatory conditions.
Keywords
Celiac Disease Takayasu Arteritis Osteoid Osteoma Pyoderma Gangrenosum Chronic Recurrent Multifocal OsteomyelitisBibliography
- 1.Aksentijevich I, Masters SL, Ferguson PJ, Dancey P, Frenkel J, van Royen-Kerkhoff A, Laxer R, Tedgård U, Cowen EW, Pham TH, Booty M, Estes JD, Sandler NG, Plass N, Stone DL, Turner ML, Hill S, Butman JA, Schneider R, Babyn P, El-Shanti HI, Pope E, Barron K, Bing X, Laurence A, Lee C-CR, Chapelle D, Clarke GI, Ohson K, Nicholson M, Gadina M, Yang B, Korman BD, Gregersen PK, van Hagen PM, Hak AE, Huizing M, Rahman P, Douek DC, Remmers EF, Kastner DL, Goldbach-Mansky R. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med. 2009;360(23):2426–37.CrossRefPubMedPubMedCentralGoogle Scholar
- 2.Almeida de Jesus A, Goldbach-Mansky R. Monogenic autoinflammatory diseases:concept and clinical manifestations. Clin Immunol. 2013;147(3):155–74.CrossRefPubMedGoogle Scholar
- 3.Beck C, Girschick HJ, Morbach H, Schwarz T, Yimam T, Frenkel J, van Gijn ME. Mutation screening of the IL-1 receptor antagonist gene in chronic non-bacterial osteomyelitis of childhood and adolescence. Clin Exp Rheumatol. 2011;29(6):1040–3.PubMedGoogle Scholar
- 4.Beck C, Morbach H, Beer M, Stenzel M, Tappe D, Gattenlohner S, Hofmann U, Raab P, Girschick HJ. Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther. 2010;12:R74.CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Castori M, Sinibaldi L, Mingarelli R, Lachman RS, Rimoin DL, Dallapiccola B. Pachydermoperiostosis: an update. Clin Genet. 2005;68:6477–86.CrossRefGoogle Scholar
- 6.Eleftheriou D, Gerschman T, Sebire N, Woo P, Pilkington CA, Brogan PA. Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology. 2010;49(8):1505–12.CrossRefPubMedGoogle Scholar
- 7.El-Shanti HI, Ferguson PJ. Chronic recurrent multifocal osteomyelitis: a concise review and genetic update. Clin Orthop Relat Res. 2007;462:11–9.CrossRefPubMedGoogle Scholar
- 8.Ferguson PJ. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet. 2005;42(7):551–7.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Ferguson PJ, El-Shanti HI. Autoinflammatory bone disorders. Curr Opin Rheumatol. 2007;19(5):492–8.CrossRefPubMedGoogle Scholar
- 10.Ferguson PJ, Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep. 2012;14(2):130–41.CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Fritz J, Tzaribatchev N, Claussen CD, Carrino JA, Horger MS. Chronic recurrent multifocal osteomyelitis: comparison of whole-body MR imaging with radiography and correlation with clinical and laboratory data. Radiology. 2009;252(3):842–8.CrossRefPubMedGoogle Scholar
- 12.Gikas PD, Islam L, Aston W, Tirabosco R, Saifuddin A, Briggs TWR, Cannon SR, O’Donnell P, Jacobs B, Flanagan AM. Nonbacterial osteitis: a clinical, histopathological, and imaging study with a proposal for protocol-based management of patients with this diagnosis. J Orthop Sci. 2009;14(5):505–16.CrossRefPubMedGoogle Scholar
- 13.Girschick HJ, Huppertz HI, Harmsen D, Krauspe R, Müller-Hermelink HK, Papadopoulos T. Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing. Hum Pathol. 1999;30(1):59–65.CrossRefPubMedGoogle Scholar
- 14.Girschick HJ, Raab P, Surbaum S, Trusen A, Kirschner S, Schneider P, Papadopoulos T, Müller-Hermelink HK, Lipsky PE. Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis. 2005;64(2):279–85.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Girschick HJ, Zimmer C, Klaus G, Darge K, Dick A, Morbach H. Chronic recurrent multifocal osteomyelitis: what is it and how should it be treated? Nat Clin Pract Rheumatol. 2007;3(12):733–8.CrossRefPubMedGoogle Scholar
- 16.Gleeson H, Wiltshire E, Briody J, Hall J, Chaitow J, Sillence D, Cowell C, Munns C. Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. J Rheumatol. 2008;35:707–12.PubMedGoogle Scholar
- 17.Golla A, Jansson A, Ramser J, Hellebrand H, Zahn R, Meitinger T, Belohradsky BH, Meindl A. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet. 2002;10:217–21.CrossRefPubMedGoogle Scholar
- 18.Hamel J, Paul D, Gahr M, Hedrich CM. Pilot study: possible association of IL10 promoter polymorphisms with CRMO. Rheumatol Int. 2011. doi: 10.1007/s00296-010-1768-8.PubMedGoogle Scholar
- 19.Hofmann SR, Schwarz T, Moller JC, Morbach H, Schnabel A, Rosen-Wolff A, Girschick HJ, Hedrich CM. Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol. 2011;141:317–27.CrossRefPubMedGoogle Scholar
- 20.Hospach T, Langendoerfer M, von Kalle T, Maier J, Dannecker GE. Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. Eur J Pediatr. 2010;169:1105–11.CrossRefPubMedGoogle Scholar
- 21.Huber AM, Lam PY, Duffy CM, Yeung RS, Ditchfield M, Laxer D, Cole WG, Kerr Graham H, Allen RC, Laxer RM. Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J Pediatr. 2002;141:198–203.CrossRefPubMedGoogle Scholar
- 22.Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, Grote V, Diebold J, Jansson V, Schneider K, Belohradsky BH. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford). 2007;46(1):154–60.CrossRefGoogle Scholar
- 23.Jesus AA, Osman M, Silva CA, Kim PW, Pham TH, Gadina M, et al. A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil. Arthritis Rheum. 2011;63(12):4007–17.CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Khanna G, Sato TS, Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics. 2009;29:1159–77.CrossRefPubMedGoogle Scholar
- 25.Kim JE, Kolh EM, Kim DK. Takayasu’s arteritis presenting with focal periostitis affecting two limbs. Int J Cardiol. 1998;67:267–70.CrossRefPubMedGoogle Scholar
- 26.Laxer RM, Shore AD, Manson D, King S, Silverman ED, Wilmot DM. Chronic recurrent multifocal osteomyelitis and psoriasis—a report of a new association and review of related disorders. Semin Arthritis Rheum. 1988;17:260–70.CrossRefPubMedGoogle Scholar
- 27.Majeed HA, Kalaawi M, Mohanty D, Teebi AS, Tunjekar MF, al-Gharbawy F, Majeed SA, al-Gazzar AH. Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J Pediatr. 1989;115(5):730–4.CrossRefPubMedGoogle Scholar
- 28.Master SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009;27(1):621–68.CrossRefGoogle Scholar
- 29.Miettunen PM, Wei X, Kaura D, Reslan WA, Aguirre AN, Kellner JD. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J. 2009;7:2. This is a prospective analysis of response to bisophosphonates in nine children with CRMO.CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Morbach H, Dick A, Beck C, Stenzel M, Muller-Hermelink HK, Raab P, Girschick HJ. Association of chronic non-bacterial osteomyelitis with Crohn’s disease but not with CARD15 gene variants. Rheumatol Int. 2010;30:617–21.CrossRefPubMedGoogle Scholar
- 31.Morbach H, Hedrich CM, Beer M, Girschick HJ. Autoinflammatory bone disorders. Clin Immunol. 2013;147(3):185–96.CrossRefPubMedGoogle Scholar
- 32.Morbach H, Schneider P, Schwarz T, Hofmann C, Raab P, Neubauer H, Düren C, Beer M, Girschick HJ. Comparison of magnetic resonance imaging and 99mTechnetium-labelled methylene diphosphonate bone scintigraphy in the initial assessment of chronic non-bacterial osteomyelitis of childhood and adolescents. Clin Exp Rheumatol. 2012;30(4):578–82.PubMedGoogle Scholar
- 33.Paller AS, Pachman L, Rich K, Esterly NB, Gonzalez-Crussi F. Pustulosis palmaris et plantaris: its association with chronic recurrent multifocal osteomyelitis. J Am Acad Dermatol. 1985;12:927–30.CrossRefPubMedGoogle Scholar
- 34.Papadaki ME, Lietman SA, Levine MA, Olsen BR, Kaban LB, Reichenberge EJ. Cherubism: best clinical practice. Orphanet J Rare Dis. 2012;7(1):S6.CrossRefPubMedPubMedCentralGoogle Scholar
- 35.Ravelli A, Marseglia GL, Viola S, Ruperto N, Martini A. Chronic recurrent multifocal osteomyelitis with unusual features. Acta Paediatr. 1995;84:222–5.CrossRefPubMedGoogle Scholar
- 36.Reddy S, Jia S, Geoffrey R, Lorier R, Suchi M, Broeckel U, et al. An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N Engl J Med. 2009;360(23):2438–44.CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Schnellbacher C, Ciocca G, Menendez R, Aksentijevich I, Goldbach-Mansky R, Duarte AM, et al. Deficiency of interleukin-1 receptor antagonist responsive to anakinra. Pediatr Dermatol. 2012:1–2.Google Scholar
- 38.Schultz C, Holterhus PM, Seidel A, Jonas S, Barthel M, Kruse K, Bucsky P. Chronic recurrent multifocal osteomyelitis in children. Pediatr Infect Dis J. 1999;18(11):1008–13.CrossRefPubMedGoogle Scholar
- 39.Scianaro R, Insalaco A, Bracci-Laudiero L, Teti A, De Benedetti F, Prencipe G. Deregulation of the IL-1β axis in the monocyte-macrophage lineage in chronic recurrent multifocal osteomyelitis. Pediatr Rheumatol Online J. 2014;12:30.CrossRefPubMedPubMedCentralGoogle Scholar
- 40.Smith EJ, Allantaz F, Bennett L, Zhang D, Gao X, Wood G, Kastner DL, Punaro M, Aksentijevich I, Pascual V, Wise CA. Clinical, molecular, and genetic characteristics of PAPA syndrome: a review. Curr Genomics. 2010;11(7):519–27.CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Stenerson M, Dufendach K, Aksentijevich I, Brady J, Austin J, Reed AM. The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist. Arthritis Rheum. 2011;63(12):4018–22.CrossRefPubMedGoogle Scholar
- 42.Twilt M, Laxer RM. Clinical care of children with sterile bone inflammation. Curr Opin Rheumatol. 2011;23:424–31.CrossRefPubMedGoogle Scholar
- 43.Whyte MP. Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci. 2010;1192:190–200.CrossRefPubMedGoogle Scholar
- 44.Wipff J, Adamsbaum C, Kahan A, Job-Deslandre C. Chronic recurrent multifocal osteomyelitis. Joint Bone Spine. 2011;78(6):555–60.CrossRefPubMedGoogle Scholar